Biolinq Incorporated: Company Research Report

Company Overview

• Name: Biolinq Incorporated

• Mission of the Company: To pioneer precision multi-analyte wearable sensors that improve metabolic health, offering a biosensor platform designed to inform and inspire healthier living.

• Founded By: Jared Tangney, PhD (Co-founder, President & CTO)

• When was the Company Founded: No information is available

• Key People in the Company:

• Rich Yang, CEO

• Jared Tangney, PhD, President & CTO

• David Arida, COO

• Naresh Bhavaraj, PhD, SVP, R&D

• Mark Brister, SVP, Engineering & Facilities

• Jeff Bishop, PhD, SVP, R&D - Chemistry

• Drew Woodmansee, VP, Legal Affairs & Head of IP

• Amy Vandenberg, VP, Regulatory & Clinical Affairs

• Todd Newhouse, VP, R&D - Sensing Hardware

• Rebecca Gottlieb, PhD, VP, Sensor R&D - Advanced Research

• Brian Kelly, MD, VP, Corporate Development

• Mina Stemm, PhD, VP, Business Development

• David Carner, VP, Quality

• Tim Sablotny, VP, Supply Chain

• Headquarters: San Diego, CA

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: Biolinq is known for developing precision multi-analyte wearable biosensors aimed at improving metabolic health.

Products

• Main Product Offering: Biolinq is known for its innovative Biowearable technology platform that leverages an array of ultra-small electrochemical sensors.

• Product Description:

• Biowearable Platform: A revolutionary platform for metabolic health that uses a series of ultra-small biosensors.

• Key Features:

• Array of Sensors: Designed for optimized insights and reliability.

• Multiple Analytes: Capable of sensing multiple analytes for comprehensive health insights.

• Real-Time Feedback: Provides real-time data derived from multiple independent sensors.

• Comfort: The device is engineered for maximum comfort and performance.

Recent Developments

• Recent Developments:

• In April 2024, Biolinq secured $58 million in funding for its glucose monitoring technology.

• The company is currently pursuing a pivotal trial geared towards FDA clearance for its intradermal glucose sensor.

• New Features/Products:

• The focus has been on developing an advanced wearable patch that utilizes electrochemical sensors to measure glucose levels from the intradermal space beneath the skin.

• Partnerships: The company has partnerships with leading universities and bioengineering institutions to develop novel solutions on its biosensor platform.

This report provides a condensed view of Biolinq Incorporated, focusing on its mission, products, and recent strategic initiatives, without speculative commentary beyond the available data.